Natrol
This article was originally published in The Tan Sheet
Executive Summary
Dietary supplement firm expects second quarter revenues will rise 10%. "Consumer demand for herbal products, which comprise an important part of Natrol's business, appears to be weak and industry-wide. There also have been significant trade inventory adjustments which have had an effect on Natrol's results for the second quarter," the firm says June 15. "Natrol's strategy continues to be to build its Natrol and Laci Le Beau brands across multiple channels of distribution, working to garner increased presence in food, drug, mass market, health food, catalog and Internet outlets"
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning